EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia

Miriam Chandad iD, Rajae Chlihfane, Safae Kodad, Bouchra Oneib, Fatima Elghazouani

Case Reports in Psychiatry · 10.05.2024 · 2024 · 1-3

DOI: 10.1155/2024/9936663 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Psychiatry, erschienen am 10.05.2024. Verfasst von Miriam Chandad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine and Pharmacy, Mother and Child Health and Mental Health Research Laboratory, Mohammed I University, Ouj…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of neuroleptic malignant syndrome justifies the immediate discontinuation of the drug in question and the reinstitution of therapy with another drug. In the case of resistant schizophrenia treated with clozapine, there are insufficient therapeutic options. We report the case of a young patient followed up for resistant schizophrenia who developed neuroleptic malignant syndrome after 5 years of therapy with clozapine. Clozapine therapy was successfully reinitiated, and the dosage was increased to 300 mg/day over 62 days. In light of this clinical case and a review of the literature, we report the possibility of reintroducing clozapine following an incidence of malignant syndrome in patients with resistant schizophrenia with respect to certain rules; in particular, a slow increase in dose after a reasonable period of time and close monitoring.

Autor:innen und Institutionen

  • Department of Psychiatry, Faculty of Medicine and Pharmacy, Mother and Child Health and Mental Health Research Laboratory, Mohammed I University, Oujda, Morocco.

ORCID-Profile: Miriam Chandad

Zitieren

APA

Chandad, M., Chlihfane, R., Kodad, S., Oneib, B., & Elghazouani, F. (2024). Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia. Case Reports in Psychiatry, 2024, 1-3. https://doi.org/10.1155/2024/9936663

Vancouver

Chandad M, Chlihfane R, Kodad S, Oneib B, Elghazouani F. Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia. Case Reports in Psychiatry. 2024;2024:1-3. doi:10.1155/2024/9936663

BibTeX
@article{Chandad2024,
  author = {Chandad, Miriam and Chlihfane, Rajae and Kodad, Safae and Oneib, Bouchra and Elghazouani, Fatima},
  title = {Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia},
  journal = {Case Reports in Psychiatry},
  year = {2024},
  volume = {2024},
  pages = {1--3},
  doi = {10.1155/2024/9936663}
}
Kostenlos starten →